Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-153188)

Filing Details

Accession Number:: 0001209191-16-153188
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2016-12-02 21:04:02
Reporting Period:: 2016-11-22

Filing Date:: 2016-12-02
Accepted Time:: 2016-12-02 21:04:02
Original Submission Date:: 2016-11-23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326110	Nantkwest Inc.	NK	Biological Products, (No Disgnostic Substances) (2836)	431979754

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1424620	C John Thomas	C/O Nantkwest, Inc. 3530 John Hopkins Court San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-11-23	7,719	$7.50	315,070	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This amendment is filed to include 719 shares sold by the reporting person on November 23, 2016. These 719 shares were incorrectly included in the amount of shares beneficially owned by the reporting person in a subsequent Form 4 filed November 29, 2016.